Cargando…

Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder

Calciprotein particles (CPPs) are a new biological marker of chronic kidney disease-mineral and bone disorder (CKD-MBD). CPPs consist of phosphate, calcium, and some proteins, with phosphate being the major contributor to the level and biological activity of CPPs. Recent studies have shown the physi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiyama, Kenichi, Kimura, Takaaki, Shiizaki, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892265/ https://www.ncbi.nlm.nih.gov/pubmed/29780418 http://dx.doi.org/10.1155/2018/5282389

Ejemplares similares

Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease
por: Miura, Yutaka, et al.
Publicado: (2018)

Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology
por: Kutikhin, Anton G., et al.
Publicado: (2021)

Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the Macrophage
por: Smith, Edward R., et al.
Publicado: (2013)

Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease
por: Bruell, S., et al.
Publicado: (2022)

Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs
por: Miura, Marina, et al.
Publicado: (2023)

Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers
por: Koeppert, Sina, et al.
Publicado: (2021)

Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease
por: Silaghi, Ciprian N., et al.
Publicado: (2020)

Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease
por: Tiong, Mark K, et al.
Publicado: (2021)

Calciprotein Particles Link Disturbed Mineral Homeostasis with Cardiovascular Disease by Causing Endothelial Dysfunction and Vascular Inflammation
por: Shishkova, Daria K., et al.
Publicado: (2021)

Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity
por: Köppert, Sina, et al.
Publicado: (2018)

Calciprotein Particles Cause Endothelial Dysfunction under Flow
por: Shishkova, Daria, et al.
Publicado: (2020)

The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients
por: Nakamura, Kimihiko, et al.
Publicado: (2019)

Klotho and calciprotein particles as therapeutic targets against accelerated ageing
por: Kuro-o, Makoto
Publicado: (2021)

Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential
por: Zeper, Lara W., et al.
Publicado: (2022)

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial
por: Smith, Edward R., et al.
Publicado: (2020)

Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function
por: Tiong, Mark K., et al.
Publicado: (2022)

Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification
por: ter Braake, Anique D, et al.
Publicado: (2019)

Calciprotein Particles Induce Endothelial Dysfunction by Impairing Endothelial Nitric Oxide Metabolism
por: Feenstra, Lian, et al.
Publicado: (2023)

Chronic Kidney Disease-Mineral and Bone Disorder
por: Lee, Wen-Chin, et al.
Publicado: (2017)

Chronic kidney disease mineral and bone disorder in children
por: Wesseling, Katherine, et al.
Publicado: (2007)

Calciprotein Particles Cause Physiologically Significant Pro-Inflammatory Response in Endothelial Cells and Systemic Circulation
por: Shishkova, Daria, et al.
Publicado: (2022)

Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist
por: Ogata, Masatomo, et al.
Publicado: (2022)

Calciprotein particles and fibroblast growth factor 23 contribute to the pathophysiology of hypercalcemia in a patient with renal sarcoidosis
por: Iwazu, Yoshitaka, et al.
Publicado: (2019)

Association between amorphous calcium-phosphate ratios in circulating calciprotein particles and prognostic biomarkers in hemodialysis patients
por: Nakamura, Kimihiko, et al.
Publicado: (2022)

Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
por: Thiem, Ursula, et al.
Publicado: (2022)

Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis
por: Jäger, Elisabeth, et al.
Publicado: (2020)

Effects of fetuin-A-containing calciprotein particles on posttranslational modifications of fetuin-A in HepG2 cells
por: Uedono, Hideki, et al.
Publicado: (2021)

Which Outcome in Chronic Kidney Disease-Mineral and Bone Disorder Patients?
por: Cozzolino, Mario
Publicado: (2014)

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
por: Zaloszyc, Ariane, et al.
Publicado: (2023)

Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)
por: Misof, Barbara M., et al.
Publicado: (2019)

Calciprotein particle-induced cytotoxicity via lysosomal dysfunction and altered cholesterol distribution in renal epithelial HK-2 cells
por: Kunishige, Rina, et al.
Publicado: (2020)

Effects of calcifediol supplementation on markers of chronic kidney disease‐mineral and bone disorder in dogs with chronic kidney disease
por: Parker, Valerie J., et al.
Publicado: (2020)

Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
por: Goto, Shunsuke, et al.
Publicado: (2013)

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
por: Fang, Yifu, et al.
Publicado: (2013)

Newly Developed Rat Model of Chronic Kidney Disease–Mineral Bone Disorder
por: Watanabe, Kentaro, et al.
Publicado: (2018)

A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder
por: Frauscher, Bianca, et al.
Publicado: (2017)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
por: Hou, Yi-Chou, et al.
Publicado: (2022)

The current status of chronic kidney disease-mineral and bone disorder management in China
por: Zhan, Ya, et al.
Publicado: (2022)

Relative comparison of chronic kidney disease-mineral and bone disorder rat models
por: Zhang, Xiaoqiong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_15r5h332a7208dsd09fgj4774a